VistaGen Therapeutics, Inc. Common Stock (NASDAQ: VTGN) last traded at $0.207, down 3.82% on the session. The quote above updates while this page is open; the figures below are drawn from VistaGen Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
VistaGen Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker VTGN. Its market capitalisation is $9.17 million.
Valuation measures for VistaGen Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $9.17M |
|---|---|
| Enterprise value | $3.43M |
| Price / sales | 3.67 |
| Price / book | 0.37 |
| Beta | 1.27 |
Trailing-twelve-month figures tagged in VistaGen Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $2.50M |
|---|---|
| Net income (TTM) | -$67.62M |
| EPS (TTM) | -$1.66 |
| Operating margin | -2785.69% |
| Return on equity | -276.21% |
| Cash | $16.99M |
Range and volume for VTGN over the past 52 weeks.
| 52-week high | $5.14 |
|---|---|
| 52-week low | $0.200 |
| Volume | 945.1K |
| Average volume | 12.15M |
| Previous close | $0.215 |
Invest a chosen dollar amount in VistaGen Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell VTGN.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.